@misc{misc, title  = {{Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials}},

 url = {{http://dx.doi.org/10.21203/rs.3.rs-2205394/v1 }},

 year = {{2022}},

 month = {{12}},

 author = {{Rugo HS and Poznak CHV and Neven P and Danielewicz I and Lee SC and Campone M and Chik JYK and Alonso EV and Naume B and Brain E and Siegel JM et al}},

 doi = {{10.21203/rs.3.rs-2205394/v1}},

 note = {{Accessed on 2025/10/10}}}